Atlas Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines

Clinical trial NCT01189747 · COMPLETED

Trial details

NCT number
NCT01189747
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lateral Canthus RhytidesCrow's Feet Lines
Start date
2010-10-01
Primary completion
2011-04-01
Enrollment
446

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.